News
Urgent need to apply new rules on medical devices 14-10-2019
ESIP argues for no delay in application of the MDR
At the end of May 2017, after long and intensive political debate, the new European Medical Device Regulation (Regulation EU 2017/745; MDR) entered into force. Its main goals are to increase the safety of medical devices placed on the market, to raise the requirements for the clinical evaluation of high-risk devices, to establish transparency by implementing a central database that is at least in part publicly accessible, and to harmonise the quality of Notified Bodies throughout Europe.
Putting social welfare at the heart of EU policy 12-09-2019
ESIP gathers stakeholders to discuss mainstreaming EU social policy
On 11 September, the European Social Insurance Platform (ESIP) gathered a panel of high-level social policy experts from the main EU institutions to discuss how to give social welfare a high level of priority on the EU agenda.
Regulation on orphan medicines: a target for abuse 14-06-2019
Adressing the market failures in the orphan medicinal products
At the end of 2017, the European Commission launched a joint evaluation of the legislation on paediatric and orphan medicinal products (OMPs). The European Social Insurance Platform (ESIP), welcomes the initiative of evaluating Regulation nº 141/2000 on OMPs and takes this opportunity to raise concerns regarding its implementation.
For an ambitious role of the EU in health 07-05-2019
ESIP position paper on EU health policy
Within its strategic recommendations to EU leaders, the European Commssion stated that the European Union needs to support high-quality, affordable and accessible healthcare. In order to ensure that this is indeed the case, healthcare payers represented by ESIP put forward a position paper on the future health policy of the EU.
